Company intelligence / Profile preview

Sanulac

Johannesburg, Gauteng, South Africaalula.co.nz ↗

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Sanulac manufactures and markets a range of infant formulas and nutritional products for infants and young children. The company’s portfolio includes both standard milk-based formulas as well as specialty formulas for specific dietary needs. It operates primarily in South Africa but has expanded into other African markets. There are no clinical trial results since the business focuses on regulated food/nutrition rather than pharmaceuticals or biotech drugs.

Therapeutic areas: Metabolic DisordersWomen's Health
Industry: Food & Nutrition

Partnerships

Partnerships with hospitals, clinics, pharmacies across Southern Africa for distribution

Beyond the preview

Go deeper on Sanulac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanulac.

Explore the full profile